SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Director Douglas Kerr filed a Form 144 notice of intent to sell 2,604…

Dyne Therapeutics, Inc. · 144 filed Nov 13, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 13, 2026 at 16:05 ET

Director Douglas Kerr filed a Form 144 notice of intent to sell 2,604 shares of Dyne Therapeutics common stock, with an estimated aggregate market value of approximately $43,810. The shares were acquired through restricted stock unit vesting and equity compensation. The sale is small relative to the company's $3.4B market cap and represents a routine insider transaction.

  • Director Douglas Kerr filed Form 144 on 2026-11-13 to sell 2,604 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $43,810.
  • Shares were acquired via restricted stock unit vesting and equity compensation.
  • The filing indicates a prior sale of 3,745 shares on 2026-09-04 and 1,290 shares on 2026-09-08.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access